Psychomotor Agitation Non-responsive to Treatment: A Case Report of Phenibut Withdrawal Syndrome
Background and Objectives: Phenibut (4-amino-3-phenyl-butyric acid), acting as a GABA-B receptor agonist, has a beneficial effect on anxiety. Although its medical use is not approved in western countries, it can be easily obtained worldwide via the Internet, so it spread as a substance of abuse. In...
Main Authors: | Cecilia Maria Esposito, Gian Mario Mandolini, Giuseppe Delvecchio, Alessio Fiorentini, Paolo Brambilla |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2021.688147/full |
Similar Items
-
Acute phenibut withdrawal: A comprehensive literature review and illustrative case report
by: Matthew I Hardman, et al.
Published: (2018-12-01) -
STUDY OF PHENIBUT ANTIEDEMIC ACTION AND NEW GABA DERIVATIVES
by: T. N. Scherbakova, et al.
Published: (2015-09-01) -
Psychoimmunomodulating activity of Phenibut under conditions of experimental hyperthyroidism
Published: (2012-03-01) -
The Management of Psychomotor Agitation Associated with Schizophrenia or Bipolar Disorder: A Brief Review
by: Maurizio Pompili, et al.
Published: (2021-04-01) -
Psychiatric emergencies: psychomotor agitation management and suicide risk assessment
by: Cristina Marta Del-Ben, et al.
Published: (2017-02-01)